BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17488771)

  • 1. Protective effect of an acute oral loading dose of trimetazidine on myocardial injury following percutaneous coronary intervention.
    Bonello L; Sbragia P; Amabile N; Com O; Pierre SV; Levy S; Paganelli F
    Heart; 2007 Jun; 93(6):703-7. PubMed ID: 17488771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of metabolic manipulator trimetazidine in limiting percutaneous coronary intervention-induced myocardial injury.
    Kazmi DH; Kapoor A; Sinha A; Ambesh P; Kashyap S; Khanna R; Kumar S; Garg N; Tewari S; Goel PK
    Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S365-S371. PubMed ID: 30595291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the myocardial protection of trimetazidine during percutaneous coronary intervention: a multi-center randomized and controlled clinical study].
    Chen YD; Zhao LK; Tian F; Du ZM; Jiang H; Wei M
    Zhonghua Nei Ke Za Zhi; 2010 Jun; 49(6):473-6. PubMed ID: 20979731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimetazidine administration minimizes myocardial damage and improves left ventricular function after percutaneous coronary intervention.
    Labrou A; Giannoglou G; Zioutas D; Fragakis N; Katsaris G; Louridas G
    Am J Cardiovasc Drugs; 2007; 7(2):143-50. PubMed ID: 17503885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures.
    Onbasili AO; Yeniceriglu Y; Agaoglu P; Karul A; Tekten T; Akar H; Discigil G
    Heart; 2007 Jun; 93(6):698-702. PubMed ID: 17065180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of trimetazidine therapy on left ventricular function after percutaneous coronary intervention].
    Xu XH; Zhang WJ; Zhou YJ; Zhou ZM; Ma HY; Hu B; Kang YP; Luo FF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Mar; 41(3):205-9. PubMed ID: 23879944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of trimetazidine on incidence of myocardial injury and contrast-induced nephropathy in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention.
    Shehata M
    Am J Cardiol; 2014 Aug; 114(3):389-94. PubMed ID: 24927970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of trimetazidine treatment in patients with type 2 diabetes undergoing percutaneous coronary intervention for AMI.
    Li R; Tang X; Jing Q; Wang Q; Yang M; Han X; Zhao J; Yu X
    Am J Emerg Med; 2017 Nov; 35(11):1657-1661. PubMed ID: 28587952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical outcomes of trimetazidine in patients with acute ST segment elevation myocardial infarction without ST segment resolution after primary percutaneous coronary intervention].
    Peng JJ; Ma ZM; Ren WL; Ren LH; Lei LC; Liang Y
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1399-401. PubMed ID: 19671333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of pravastatin pre-treatment on periprocedural microcirculatory damage in patients undergoing percutaneous coronary intervention.
    Fujii K; Kawasaki D; Oka K; Akahori H; Iwasaku T; Fukunaga M; Eguchi A; Sawada H; Masutani M; Lee-Kawabata M; Tsujino T; Ohyanagi M; Masuyama T
    JACC Cardiovasc Interv; 2011 May; 4(5):513-20. PubMed ID: 21596324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Increase in troponin levels after coronary angioplasty (PTCA) in stable angina pectoris].
    Varvarovský I; Brtko M; Branny M
    Vnitr Lek; 2004 Mar; 50(3):203-7. PubMed ID: 15125370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement and prevention of myocardial injury during percutaneous coronary intervention.
    Schiano P; Gabriel Steg P
    Heart; 2007 Jun; 93(6):656-7. PubMed ID: 17502648
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].
    Plak M; Orliński L; Łobos M; Ciesielczyk M; Wlazeł RN; Paradowski MT
    Pol Merkur Lekarski; 2010 Jun; 28(168):444-9. PubMed ID: 20642101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical detection of minor myocardial injury after elective, uncomplicated, successful percutaneous coronary intervention in patients with stable angina: clinical outcome.
    Saadeddin SM; Habbab MA; Sobki SH; Ferns GA
    Ann Clin Biochem; 2002 Jul; 39(Pt 4):392-7. PubMed ID: 12117443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Trimetazidine in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis.
    Zhang Y; Ma XJ; Shi DZ
    PLoS One; 2015; 10(9):e0137775. PubMed ID: 26367001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High high-density lipoprotein-cholesterol reduces risk and extent of percutaneous coronary intervention-related myocardial infarction and improves long-term outcome in patients undergoing elective percutaneous coronary intervention.
    Sattler KJ; Herrmann J; Yün S; Lehmann N; Wang Z; Heusch G; Sack S; Erbel R; Levkau B
    Eur Heart J; 2009 Aug; 30(15):1894-902. PubMed ID: 19474052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicorandil prevents microvascular dysfunction resulting from PCI in patients with stable angina pectoris: a randomised study.
    Hirohata A; Yamamoto K; Hirose E; Kobayashi Y; Takafuji H; Sano F; Matsumoto K; Ohara M; Yoshioka R; Takinami H; Ohe T
    EuroIntervention; 2014 Jan; 9(9):1050-6. PubMed ID: 24457276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of peri-procedural myocardial injury using a single high loading dose of rosuvastatin.
    Cay S; Cagirci G; Sen N; Balbay Y; Durmaz T; Aydogdu S
    Cardiovasc Drugs Ther; 2010 Feb; 24(1):41-7. PubMed ID: 20217203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial.
    Ferrari R; Ford I; Fox K; Challeton JP; Correges A; Tendera M; Widimský P; Danchin N;
    Lancet; 2020 Sep; 396(10254):830-838. PubMed ID: 32877651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different prognostic importance of elevated troponin I after percutaneous coronary intervention in acute coronary syndrome and stable angina pectoris.
    Gravning J; Ueland T; Mørkrid L; Endresen K; Aaberge L; Kjekshus J
    Scand Cardiovasc J; 2008 Jun; 42(3):214-21. PubMed ID: 18569954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.